Zinc Supplementation: What the Evidence Says

Quick Answer

Zinc Supplementation has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Therefore, abnormal zinc levels are closely associated with the occurrence and progression of liver diseases, particularly cirrhosis. [Gong Yifan (2026); evidence level 1]
• Acquired zinc deficiency is commonly caused by insufficient zinc intake, malabsorption, increased demand, or excessive loss. [Gong Yifan (2026); evidence level 1]
• Clinically, this presents as an increased propensity for infections, cancer, and autoimmune diseases and an impaired vaccination response in elderly patients. [Olah Krisztina (2026); evidence level 4]
• Markers of immunosenescence include a decline in Th1 response and reduced lymphocyte counts. [Olah Krisztina (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For zinc supplementation, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Gong Yifan (2026). Zinc supplementation in liver cirrhosis: meta-analysis of its effect on biochemical and clinical outcomes. DOI: 10.1186/s40795-025-01239-3. PMCID: PMC12825225. PMID: 41527112. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12825225/
• Olah Krisztina (2026). Zinc Supplementation Partially Reconstitutes Impaired Interferon-γ Production in the Elderly. DOI: 10.3390/ijms27021039. PMCID: PMC12842025. PMID: 41596683. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12842025/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.